Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Chuck Schmeling who wrote (8383)	3/5/1998 12:47:00 PM
From: J.F.	Read Replies (2) \| Respond to of 14328

The way it's been runnin since earnings hit the wire it could hit a 1/4 mill traded for the day. Be interesting to see which way it'll end up... jf...

To: Chuck Schmeling who wrote (8383)	3/5/1998 1:41:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 14328

Reason it's down is a significant EPS downward surprise. QTR4 was projected for .03, so we have a 33% downsude surprise. Do we have a growing company with a good foundations? Yes. Did TRIBY come in way under expectations? Yes. Next year TRIBY is projected to be at .15 for the year. If TRIBY is going avoid another downside surprise, next QTR better hit .03. In the recent TRIBY test summary posted here, a couple potential winners were not slated to be available till April 98, so they can't help the 1st qtr #s. Looks like our upside will be very limited until qtr2 results are in (assuming they will be strong), unless we get either the Uni-Gold HIV FDA approval and/or a good resolution to the SLF case in the interim, IMSCO Scott